Equities research analysts forecast that Proto Labs Inc (NYSE:PRLB) will report sales of $116.40 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Proto Labs’ earnings, with the lowest sales estimate coming in at $115.90 million and the highest estimate coming in at $117.00 million. Proto Labs posted sales of $109.65 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 6.2%. The business is expected to report its next earnings report on Thursday, July 25th.
On average, analysts expect that Proto Labs will report full year sales of $477.36 million for the current year, with estimates ranging from $470.68 million to $481.20 million. For the next financial year, analysts expect that the company will report sales of $533.50 million, with estimates ranging from $513.71 million to $548.00 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow Proto Labs.
Proto Labs (NYSE:PRLB) last announced its earnings results on Thursday, April 25th. The industrial products company reported $0.69 EPS for the quarter, topping the Zacks’ consensus estimate of $0.61 by $0.08. Proto Labs had a return on equity of 13.86% and a net margin of 16.41%. The company had revenue of $113.50 million for the quarter, compared to analysts’ expectations of $115.24 million. During the same period last year, the firm earned $0.71 EPS. Proto Labs’s revenue for the quarter was up 5.4% compared to the same quarter last year.
Proto Labs stock traded down $1.31 during trading on Friday, reaching $101.15. The company had a trading volume of 249,415 shares, compared to its average volume of 177,163. Proto Labs has a 52 week low of $94.20 and a 52 week high of $166.60. The company has a debt-to-equity ratio of 0.02, a quick ratio of 4.67 and a current ratio of 4.89. The stock has a market cap of $2.72 billion, a P/E ratio of 36.00, a P/E/G ratio of 1.39 and a beta of 1.60.
A number of hedge funds have recently modified their holdings of the business. Executive Wealth Management LLC purchased a new position in shares of Proto Labs during the fourth quarter valued at about $30,000. Parallel Advisors LLC purchased a new position in shares of Proto Labs during the first quarter valued at about $34,000. Brand Asset Management Group Inc. purchased a new position in shares of Proto Labs during the first quarter valued at about $45,000. Icon Wealth Partners LLC purchased a new position in shares of Proto Labs during the first quarter valued at about $57,000. Finally, Nikko Asset Management Americas Inc. grew its position in shares of Proto Labs by 530.8% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 656 shares of the industrial products company’s stock valued at $74,000 after purchasing an additional 552 shares in the last quarter. Institutional investors and hedge funds own 91.83% of the company’s stock.
Proto Labs Company Profile
Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets.
Featured Story: Do You Need a Fiduciary?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.